Well it's rarely dull with Recce!
What's weird about this trial is that there is no control arm. You would think a standard-care control would be a no-brainer for such a trial. How it can really be a proper phase 2 without one?
So all the "cured" patients that they will undoubtedly be talking about next week are probably also on a cocktail of antibiotics and topical treatments. How can we know what actually cured them?
Well it's rarely dull with Recce! What's weird about this trial...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22588 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 28921 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |